First and last post hereSince the guy pump his "future" stock Pharmacielo in my group, lets make a reality check. There is money to make in the latin american market so I am not here to bash Khiron, nor Pharmacielo. I copied and pasted what I wrote in my group.
I read a lot more about Pharmacelio. ACB has also licences in Columbia and they bought ICC labs in Uruguay, where it is lot more stable politically and a lot less violent than in Columbia.
These productions will be for the latin american market only. These are old stories so I will not expand. As for Pharmacielo, I was surprised about their production claim and cost but they will sell in the latin america market as ACB will also do. Their cannabis growing over there will not come to Canada and internationally. The way you posted (JFR1611) look like you thought Pharmacello would take Canada over, LOL!
With a tropical climate ideal for cultivating cannabis, experienced growers, comparatively low wages and a population of 50 million, Canadian firms see Colombia as an ideal place to invest.
They're hoping to use it as a hub for cultivating and refining medical cannabis in order to eventually export across Latin America, a region with a population of 630 million.
Conclusion; (JFR1611), there is money to be done in the latin american market but do not dream in color.